Story perspectives
Pharma Mergers Stumble Amid Economic Uncertainty and Tariffs
3/26/2025
50 3
1 of 1
Story summary
- Pharmaceutical and biotech mergers are hitting a snag as uncertainty looms over U.S. economic policies under President Trump. Executives find themselves preoccupied with fluctuating tariffs and geopolitical tensions. Although smaller deals might keep growth alive, the prevailing caution among investors signals a troubling trend for larger firms eyeing acquisitions.
